Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Marks Marine Pharmacy
WARNING LETTER
•Marks Marine Pharmacy•August 23, 2012

Marks Marine Pharmacy – FDA Warning Letter, Aug 23, 2012

Record Details

On August 23, 2012, the FDA issued a Warning Letter to Mark's Marine Pharmacy in Vancouver, B.C., for illegally promoting and selling clobazam, an unapproved and misbranded new drug, to U.S. patients and healthcare professionals. The pharmacy violated sections 502(f) and 505(a) of the FD&C Act [21 U.S.C. §§ 352(f) and 355(a)], and prohibited acts under sections 301(a) and 301(d) [21 U.S.C. §§ 331(a) and 331(d)].

The FDA stated that clobazam is an unapproved new drug because no approved application under section 505 of the FD&C Act exists for any clobazam product other than Lundbeck’s ONFI Tablets, approved October 21, 2011. Mark's Marine Pharmacy sent letters to U.S. patients and physicians advertising their ability to supply Canadian clobazam for non-Lennox-Gastaut Syndrome patients, despite ONFI's specific approval for that condition.

Furthermore, the clobazam product was deemed misbranded under section 502(f)(1) [21 U.S.C. § 352(f)(

Company
Marks Marine Pharmacy
Inspection date
August 23, 2012
Product type
Drugs
Office
Department of Health and Human Services
Person
  • Thomas (TJ) Christl (Office Director)
View Company Profile

ID · d745e957-3dd7-43a0-b344-35d97d85c8d0

Violation Codes7
21 U.S.C. 352(f)21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(p)21 U.S.C. 352(f)(1)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Marks Marine Pharmacy
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.